Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea
· Delayed Price · Currency is KRW 6,760.00
-40.00 (-0.59%)
Last updated: Apr 29, 2026, 2:19 PM KST
Kyongbo Pharmaceutical Revenue
In the year 2025, Kyongbo Pharmaceutical had annual revenue of 264.10B KRW with 10.71% growth. Kyongbo Pharmaceutical had revenue of 71.22B in the quarter ending December 31, 2025, with 20.07% growth.
Revenue
264.10B
Revenue Growth
+10.71%
P/S Ratio
0.62
Revenue / Employee
n/a
Employees
n/a
Market Cap
162.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 264.10B | 25.55B | 10.71% |
| Dec 31, 2024 | 238.56B | 22.20B | 10.26% |
| Dec 31, 2023 | 216.36B | 20.09B | 10.24% |
| Dec 31, 2022 | 196.26B | 25.61B | 15.00% |
| Dec 31, 2021 | 170.66B | -44.63B | -20.73% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ilsung Is | 64.29B |
| Dongwha Pharm.Co.,Ltd | 496.39B |
| Daihan Pharmaceutical | 208.61B |
| Hana Pharm | 139.33B |
| Jeil Pharma Holdings | 657.61B |
| HANDOK | 535.14B |
| Whan In Pharm | 255.21B |
| JW Lifescience | 257.83B |